Lupin Q4 Results
- BSE: 500257
- NSE: LUPIN
- ISIN: INE326A01037
- Sector: Biotechnology & Drugs
BSE
1,938.00
5.50 (0.28%)
5.50 (0.28%)Volume73.17 K
Updated: Fri 20 Jun, 2025 | 15:29:55
NSE
1,948.0016.20 (0.84%)
16.20 (0.84%)Volume7.53 L
Updated: Fri 20 Jun, 2025 | 15:47:45
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹5,667.13 Cr.(14.24%)
- Operating Profit₹898.94 Cr.(65.16%)
- Profit After Tax₹772.52 Cr.(114.93%)
- Operating Margin15.86%(44.57%)
Note: Comparison is on YoY basis
Quarterly - Lupin Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 5,667.13 | 5,767.71 | -1.74% | 4,960.79 | 14.24% |
| Selling/ General/ Admin Expenses Total | 1,001.25 | 984.39 | 1.71% | 900.22 | 11.22% |
| Depreciation/ Amortization | 393.18 | 271.45 | 44.84% | 457.10 | -13.98% |
| Other Operating Expenses Total | 1,687.56 | 1,695.92 | -0.49% | 1,489.97 | 13.26% |
| Total Operating Expense | 4,768.19 | 4,673.31 | 2.03% | 4,416.50 | 7.96% |
| Operating Income | 898.94 | 1,094.40 | -17.86% | 544.29 | 65.16% |
| Net Income Before Taxes | 895.84 | 1,071.27 | -16.38% | 497.71 | 79.99% |
| Net Income | 772.52 | 855.16 | -9.66% | 359.43 | 114.93% |
| Diluted Normalized EPS | 16.87 | 18.69 | -9.74% | 7.85 | 114.78% |